We have previously demonstrated that they upregulate the death ligand TRAIL in patients with chronic hepatitis B virus infection (CHB), allowing them to kill hepatocytes bearing TRAIL receptors. This evidence concerns the gene TNFSF10 and chronic hepatitis B virus infection.